tiprankstipranks
RVL Pharmaceuticals (RVLPQ)
OTHER OTC:RVLPQ
US Market
RVLPQ
RVL Pharmaceuticals
RESEARCH TOOLSreports
Want to see RVLPQ full AI Analyst Report?

RVL Pharmaceuticals (RVLPQ) Income Statement

311 Followers

RVL Pharmaceuticals Income Statement

Last quarter (Q2 2023), RVL Pharmaceuticals's total revenue was $8.26M, a decrease of -2.25% from the same quarter last year. In Q2, RVL Pharmaceuticals's net income was $-23.89M. See RVL Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 49.72M$ 17.50M$ 27.76M$ 240.03M$ 263.70M
Gross Profit
$ 40.27M$ 13.88M$ 24.47M$ 128.40M$ 121.75M
Operating Expenses
$ 99.25M$ 96.64M$ 86.21M$ 125.35M$ 116.06M
Depreciation and Amortization
$ 375.00K$ 8.18M$ 21.03M$ 57.02M$ 81.60M
EBITDA
$ -48.23M$ -71.32M$ -69.67M$ -222.80M$ -16.28M
Operating Income
$ -58.99M$ -78.71M$ -61.74M$ -280.69M$ 5.68M
Other Income/Expenses
$ 7.28M$ -3.82M$ -33.05M$ -17.33M$ -20.13M
Pretax Income
$ -51.71M$ -82.53M$ -94.80M$ -298.02M$ -118.66M
Net Income
$ -51.69M$ -64.92M$ -79.59M$ -270.90M$ -109.68M
Per Share Metrics
Basic EPS
$ -0.58$ -0.96$ -1.31$ -5.17$ -2.42
Diluted EPS
$ -0.58$ -0.96$ -1.31$ -5.17$ -2.42
Weighted Average Shares Outstanding
 89.80M 67.35M 60.65M 52.37M 45.28M
Weighted Average Shares Outstanding (Diluted)
 89.80M 67.35M 60.65M 52.37M 45.28M
Currency in USD

RVL Pharmaceuticals Earnings and Revenue History